C&O Pharmaceutical Tech (Holdings) rated 'buy' by Phillip Securities

Stock Name: C&O Pharm
Company Name: C & O PHARM TECH (HLDGS) LTD
Research House: Phillip Securities

Phillip Securities Research in a Feb 14 research report says: "2Q11 revenue was down 9.6% y-o-y to HK$153.6 million while net profit came in at HK$28.7 million (-2.7% y-o-y) as suppliers are unwilling to procure more drugs due to the uncertainties surrounding the Chinese government's healthcare policies.

Read more...